[1]谢晓川,饶莉.经导管主动脉瓣植入术临床研究进展[J].心血管病学进展,2015,(6):700-703.[doi:10.3969/j.issn.1004-3934.2015.06.011]
 XIE Xiaochuan,RAO Li.Clinical Research Progress in Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(6):700-703.[doi:10.3969/j.issn.1004-3934.2015.06.011]
点击复制

经导管主动脉瓣植入术临床研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年6期
页码:
700-703
栏目:
综述
出版日期:
2016-06-20

文章信息/Info

Title:
Clinical Research Progress in Transcatheter Aortic Valve Implantation
作者:
谢晓川饶莉
四川大学华西医院心内科,四川 成都 610041
Author(s):
XIE XiaochuanRAO Li
Cardiology Department of West China Hospital, Sichuan University, Chengdu 610041, Sichuan,China
关键词:
主动脉瓣狭窄 经导管主动脉瓣植入术 外科主动脉瓣置换术 老年人
Keywords:
aortic stenosis transcatheter aortic valve implantation surgical aortic valve replacement elderly
分类号:
R542.5
DOI:
10.3969/j.issn.1004-3934.2015.06.011
文献标志码:
A
摘要:
主动脉瓣狭窄在老年人中十分常见。通过外科手术置换瓣膜是其首选治疗方式,但部分患者因年龄偏大、身体虚弱或患有严重基础疾病而不宜进行外科手术治疗。近年来,经导管主动脉瓣植入术不断发展,并已作为外科手术的常规替代方案应用于临床。现将重点综述在老年重度主动脉瓣狭窄患者中应用经导管主动脉瓣植入术的临床研究进展。
Abstract:
Aortic valve stenosis(AS)is very common in the elderly. Surgical replacement of the valve is the standard treatment for AS, but many patients are excluded from surgery because of age, weak or have co-morbidities which increase operative risks. In recent years, trans-catheter aortic valve implantation(TAVI)has been used as an alternate treatment option for these patients. This article will emphasize on reviewing the clinical research progress in application of TAVI in elderly patients with severe aortic stenosis.

参考文献/References:

[1] Huber CH, Goeber V, Berdat P, et al. Benefits of cardiac surgery in octogenarians—a postoperative quality of life assessment[J]. Eur J Cardiothorac Surg,2007,31(6): 1099-1105.
[2] Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?[J]. Eur Heart J,2005,26(24):2714-2720.
[3] Kvidal P, Bergström R, Hörte LG, et al. Observed and relative survival after aortic valve replacement[J]. J Am Coll Cardiol,2000,35(3):747-756.
[4] Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic surgery(EACTS)and the European Society of Cardiology(ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. EuroIntervention,2008,4(2):193-199.
[5] O'Sullivan CJ, Stortecky S, Buellesfeld L, et al. Preinterventional screening of the TAVI patient: how to choose the suitable patient and the best procedure[J]. Clin Res Cardiol,2014,103(4):259-274.
[6] Bauer F, Eltchaninoff H, Tron C, et al. Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis[J]. Circulation,2004,110(11):1473-1476.
[7] Clavel MA, Webb JG, Pibarot P, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis[J]. J Am Coll Cardiol,2009,53(20):1883-1891.
[8] Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age[J]. Am J Cardiol,2010,106(12):1777-1781.
[9] Schoenenberger AW, Stortecky S, Neumann S, et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation(TAVI)[J]. Eur Heart J,2013,34(9):684-692.
[10] Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The U.K. TAVI(United Kingdom Transcatheter Aortic Valve Implantation)Registry[J]. J Am Coll Cardiol,2011,58(20):2130-2138.
[11] Blackman DJ, Baxter PD, Gale CP, et al. Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry[J]. J Interv Cardiol,2014,27(1):86-95.
[12] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med,2011,364(23):2187-2198.
[13] Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement[J]. N Engl J Med,2012,366(18):1686-1695.
[14] Nielsen HH, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial[J]. EuroIntervention,2012,8(3):383-389.
[15] Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients[J]. JACC Cardiovasc Interv,2013,6(5):443-451.
[16] D'Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis:results from an intermediate risk propensity-matched population of the Italian OBSERVANT study[J]. Int J Cardiol,2013,167(5):1945-1952.
[17] Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis(PARTNER 1): a randomised controlled trial[J].Lancet,2015,385(9986):2477-2484.
[18] Jabs A, Kilic T, Schnelle N, et al. Transcatheter aortic valve implantation and four-year follow up in a 99-year-old patient[J].J Heart Valve Dis,2013,22(2):261-264.
[19] Verouhis D, Yamasaki K, Ivert T, et al. Transcatheter aortic valve implantation is feasible and safe in nonagenarians[J]. J Am Geriatr Soc,2014,62(1):189-190.
[20] Buellesfeld L, Gerckens U, Erbel R, et al. Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation:results from the German multicenter registry[J]. J Invasive Cardiol,2012,24(10):531-536.
[21] Havakuk O, Finkelstein A, Steinvil A, et al. Comparison of outcomes in patients ≤ 85 versus > 85 years of age undergoing transcatheter aortic-valve implantation[J]. Am J Cardiol,2014,113(1):138-141.
[22] Yamamoto M, Meguro K, Mouillet G, et al. Comparison of effectiveness and safety of transcatheter aortic valve implantation in patients aged ≥ 90 years versus < 90 years[J]. Am J Cardiol,2012,110(8):1156-1163.
[23] Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association[J]. Circulation,2014,129(3): e28-e292.
[24] Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome(SOURCE)Registry:A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve[J]. Circulation,2010,122(1):62-69.
[25] Poliacikova P, Cockburn J, de Belder A, et al. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation—comparison of regimes[J]. J Invasive Cardiol,2013,25(10):544-548.
[26] Durand E, Blanchard D, Chassaing S, et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation[J]. Am J Cardiol,2014,113(2):355-360.
[27] Czerwińska-Jelonkiewicz K, Witkowski A, Dbrowski M, et al. Antithrombotic therapy—predictor of early and long-term bleeding complications after transcatheter aortic valve implantation[J]. Arch Med Sci,2013,9(6):1062-1070.
[28] Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial[J]. JAMA,2014,311(15):1503-1514.
[29] Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation:predictive factors,prognostic value,and comparison with surgical aortic valve replacement[J]. Eur Heart J,2013,31(7):865-874.
[30] Goebel N, Baumbach H, Ahad S, et al. Transcatheter aortic valve replacement: does kidney function affect outcome?[J]. Ann Thorac Surg,2013,96(2):507-512.
[31] Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients[J]. N Engl J Med,2012,366(18):1705-1715.
[32] Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis[J]. Circulation,2011,123(3):299-308.
[33] Colli A, Gallo M, Bernabeu E, et al. Aortic valve calcium scoring is a predictor of paravalvular aortic regurgitation after transcatheter aortic valve implantation[J]. Ann Cardiothorac Surg,2012,1(2):156-159.
[34] Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements[J]. J Am Coll Cardiol,2010,55(2):97-101.

相似文献/References:

[1]于海波,综述,梁延春,等.经导管主动脉瓣膜置换术后房室传导阻滞的预警[J].心血管病学进展,2016,(4):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
 YU Haibo,LIANG Yanchun.Predicting Factors of Atrioventricular Block after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2016,(6):419.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
[2]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
 YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(6):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[3]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]夏平.“8+2”心电图临床价值的研究进展夏平[J].心血管病学进展,2021,(9):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
 XIA Ping.Clinical Value of 8 Plus 2 ECG[J].Advances in Cardiovascular Diseases,2021,(6):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
[5]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
 LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(6):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[6]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
 WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[7]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
 ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(6):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
[8]达尼亚尔·迪力木拉提 施林 严飞.二叶式主动脉瓣发病机制及其临床诊治的研究进展[J].心血管病学进展,2023,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]
 Daniyar·Dilmurat,SHI Lin,YAN Fei.The PathogenesisClinical Diagnosis and Treatment of Bicuspid Aortic Valve[J].Advances in Cardiovascular Diseases,2023,(6):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]
[9]吴文军 谢玲 李婷婷 丁任重 胡义杰.经导管主动脉瓣置换术围手术期脑卒中和脑保护研究进展[J].心血管病学进展,2024,(4):295.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.002]
 WU Wenjun,XIE Ling,LI Tingting,et al.Perioperative Transcatheter Aortic Valve Replacement for Stroke and Cerebral Protection[J].Advances in Cardiovascular Diseases,2024,(6):295.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.002]
[10]吴奕璇 邓少东 陈建英.经导管主动脉瓣置换术后瓣周漏相关危险因素研究进展[J].心血管病学进展,2024,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.001]
 WU Yixuan,DENG Shaodong,CHEN Jianying.Risk Factors Related to Perivalvular Leakage After Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2024,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.001]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81270289) 作者简介:谢晓川(1991—),在读博士,主要从事扩张型心肌病基础与临床、心脏功能超声评价研究。Email: 845579525@qq.com 通信作者:饶莉(1963—),主任医师,博士,主要从事扩张型心肌病基础与临床、心脏功能超声评价研究。Email: lrlz1989@163.com
更新日期/Last Update: 2016-06-20